Prednisolone, Sulfacetamide

Odan-Cide

5 MG / ML + 100 MG / ML SolutionCanadaNot marketedAuthorised 31 Dec 1985

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Sulfacetamide Sodium and Prednisolone Sodium PhosphateUnited States · 0.23% PHOSPHATE; 10% · solution/drops · GenusSame form
BlephamideUnited States · 0.2%; 10% · suspension · AllerganSame form
Isopto CetapredUnited States · 0.25%; 10% · suspension · AlconSame form
Blephamide Eye DropsSaudi Arabia · Allergan Pharmaceuticals LTDSame substance
Cetapred Opth.Oint.Saudi Arabia · Alcon CouvreurSame substance
Isoptocetapred Eye DropsSaudi Arabia · Alcon CouvreurSame substance

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prednisolone, Sulfacetamide

Odan-Cide

5 MG / ML + 100 MG / ML SolutionCanadaNot marketedAuthorised 31 Dec 1985

Open in the registerAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Documents

The official texts, at the regulator.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Prednisolone, Sulfacetamide
Strength: 5 MG / ML + 100 MG / ML
Dosage form: Solution
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Not marketed
Status in the register: Dormant
Authorised: 31 Dec 1985
Registration: DIN 00630640
Marketing authorisation holder: Odan Laboratoriesltd
ATC code: S01CA02
Group: Sensory organs
Supply: PRESCRIPTION

BlephamidePrednisolone + Sulfacetamide · 0.2 % + 10 % · DropsCanadaCancelled

Blephamide S.O.P.Prednisolone + Sulfacetamide · 0.2 % + 10 % · OintmentCanadaCancelled

Metimyd Oph SusPrednisolone + Sulfacetamide · 5 MG / ML + 100 MG / ML · SuspensionCanadaCancelled

Vasocidin Ophthalmic SolutionPrednisolone + Sulfacetamide · 2.5 MG / ML + 100 MG / ML · LiquidCanadaCancelled

Vasocidin Ophthalmic SolutionPrednisolone + Sulfacetamide · 2.5 MG / ML + 100 MG / ML · SolutionCanadaCancelled